PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcrivon Therapeutics
Acrivon Therapeutics(ACRV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
PREXASERTIB
recurrence
,
central nervous system neoplasms
,
colorectal neoplasms
,
neoplasm metastasis
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
non-small-cell lung carcinoma
,
brain neoplasms
,
medulloblastoma
,
head and neck neoplasms
,
leukemia
,
myelomonocytic leukemia chronic
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
syndrome
,
carcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
second primary neoplasms
,
nervous system neoplasms
,
neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
rhabdomyosarcoma
,
desmoplastic small round cell tumor
,
lung neoplasms
,
small cell lung carcinoma
,
prostatic neoplasms
,
endometrial neoplasms
,
endometrioid carcinoma
Histone-arginine methyltransferase carm1
alzheimer disease
Surlorian
melanoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use